Intravitreal bevacizumab for vitreous haemorrhage

Acta Ophthalmologica

Volumn 86, Issue 5, 2008, Pages 585-586

  Jonas, Jost B ^a,b   Libondi, Teodosio ^a   Von Baltz, Stefan ^a   Vossmerbaeumer, Urs ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ADULT; AGED; CASE STUDY; CLINICAL ARTICLE; DIABETIC RETINOPATHY; DRUG EFFICACY; DRUG RESPONSE; EYE INFLAMMATION; FOLLOW UP; HUMAN; INTERVENTION STUDY; IRIS DISEASE; LASER COAGULATION; LETTER; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PSEUDOPHAKIA; RECURRENCE RISK; RETINA VEIN OCCLUSION; RISK FACTOR; RISK REDUCTION; VISUAL ACUITY; VITREOUS HEMORRHAGE;

EID: 48449083381     PISSN: 1755375X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2007.01107.x     Document Type: Letter

References (5)

1. Avery RL, Pearlman J, Pieramici DJ etal. (2006): Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 113: 1695. e1-15.
2. Mason JO III, Nixon PA & White MF (2006): Intravitreal injection of bevacizumab (Avastin) as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol 142: 685-688.
3. Oshima Y, Sakagushi H, Gomi F & Tano Y (2006): Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. Am J Ophthalmol 142: 155-158.
4. Rosenfeld PJ, Moshfeghi AA & Puliafito CA (2005): Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 36: 331-335.
5. Spaide RF & Fisger YL (2006): Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous haemorrhage. Retina 26: 275-278.